U.S. Residents

The Scientific Intake website is not intended for a U.S. audience. The website describes our product, Sensor Monitored Alimentary Restriction Therapy (SmartByte™). The product has not been cleared for marketing by the Food and Drug Administration and is not available for sale in the U.S.

SmartByte™ is limited by U.S. law to investigational use only. It has been designated Non Significant Risk by the FDA.

Outside the U.S., Scientific Intake's SmartByte™ is designated a Class I medical device and has been granted the CE Mark (Europe), and has been approved by Health Canada, Anvisa ( Brazil) and TGA (Australia).

I Understand

A large and growing body of scientific research links rapid eating with overweight and obesity in many cases

Study 2 – SmartByte™

Heather Walden, et al at the Pennington Biomedical Research Center conducted a study on Scientific Intake’s device that was published in the peer reviewed journal Obesity Research in November 2004. The study was conducted on thirty-two adults randomly assigned to the control or test groups. Day one served as a baseline for both groups, day two test group subjects ate with the device. Device subjects reduced food intake by 23%, caloric intake was 533 Cal less than the non-device control group.

It was also revealed that the device group who consumed less food did not differ on hunger levels from the control group. The abstract concludes: “These findings suggest that the use of this tool during meals significantly reduced food intake. The reduction of food intake was not associated with changes in hunger or satiety.”

© 2017 Scientific Intake Limited Co.